Company Therapeutic Solutions International, Inc. Other OTC
Equities
TSOI
US8833781011
Medical Equipment, Supplies & Distribution
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immune Modulation
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -52.12% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -52.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Timothy Dixon
CEO | Chief Executive Officer | 66 | 11-03-30 |
James Veltmeyer
CTO | Chief Tech/Sci/R&D Officer | 59 | 18-06-17 |
Feng Lin
CTO | Chief Tech/Sci/R&D Officer | 54 | 19-09-02 |
Famela Ramos
PRN | Corporate Officer/Principal | 48 | - |
Serena Robella
SAM | Sales & Marketing | - | 20-10-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Ichim
BRD | Director/Board Member | 49 | 16-01-21 |
Timothy Dixon
CEO | Chief Executive Officer | 66 | 11-03-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,230,116,869 | 3,423,983,291 ( 80.94 %) | 0 | 80.94 % |
Company contact information
Therapeutic Solutions International, Inc.
701 Wild Rose Lane
83525, Elk
+
http://www.therapeuticsolutionsint.comSector
1st Jan change | Capi. | |
---|---|---|
+8.70% | 124B | |
-7.71% | 10.93B | |
+6.05% | 9.31B | |
+23.36% | 7.6B | |
+32.10% | 5.29B | |
+8.61% | 3.45B | |
-9.10% | 2.79B | |
-2.71% | 2.3B | |
-0.20% | 2.23B |